Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease-Reference-Cited by-同舟云学术

Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease

Published:2023-04 Issue:4 Volume:31 Page:1002-1016
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Choi Jong Bin,Seol Dong-Won,Do Hyo-Sang,Yang Hee-Young,Kim Taek-Min,Byun Youkyeong Gloria,Park Jae-Min,Choi Jinhyuk,Hong Seon Pyo,Chung Won-Suk,Suh Jae Myoung,Koh Gou Young,Lee Beom Hee,Wee Gabbine,Han Yong-Mahn^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference56 articles.

1. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency;Brady;N. Engl. J. Med.,1967

2. The enzyme defect in Fabry's disease;Kint;Nature,1970

3. Vascular aspects of fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine;Rombach;Hypertension,2012

4. Fabry disease and the skin: data from FOS, the Fabry outcome survey;Orteu;Br. J. Dermatol.,2007

5. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy;Schiffmann;Nephrol. Dial. Transpl.,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial dysfunction;Journal of Molecular and Cellular Cardiology;2024-07

2. Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach;International Journal of Molecular Sciences;2023-10-21

3. From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies;Frontiers in Physiology;2023-07-19